These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32833143)

  • 21. The Vulvodynia Experience Questionnaire: Qualitative Development of a New Patient-Reported Outcome Measure for Vulvodynia.
    Goldstein AT; Diez PMQ; Kapanadze S; Cala ML; Evans CJ; Whyte JL; Christoph A
    J Sex Med; 2020 Oct; 17(10):2055-2066. PubMed ID: 32900670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and content validity testing of a patient-reported outcomes questionnaire for the assessment of hereditary angioedema in observational studies.
    Bonner N; Abetz-Webb L; Renault L; Caballero T; Longhurst H; Maurer M; Christiansen S; Zuraw B;
    Health Qual Life Outcomes; 2015 Jul; 13():92. PubMed ID: 26129930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ostomy leak impact tool: development and validation of a new patient-reported tool to measure the burden of leakage in ostomy device users.
    Nafees B; Størling ZM; Hindsberger C; Lloyd A
    Health Qual Life Outcomes; 2018 Dec; 16(1):231. PubMed ID: 30547808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of the Weight-Related Sign and Symptom Measure.
    Brod M; Højbjerre L; Pfeiffer KM; Sayner R; Meincke HH; Patrick DL
    J Patient Rep Outcomes; 2017; 2(1):17. PubMed ID: 29757304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is the EQ-5D fit for purpose in asthma? Acceptability and content validity from the patient perspective.
    Whalley D; Globe G; Crawford R; Doward L; Tafesse E; Brazier J; Price D
    Health Qual Life Outcomes; 2018 Aug; 16(1):160. PubMed ID: 30075729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of the Impact of Nighttime Urination (INTU) questionnaire to assess the impact of nocturia on health and functioning.
    Abrams S; Martin S; Gillard KK; Cheng L; Fein S
    Neurourol Urodyn; 2018 Jun; 37(5):1686-1692. PubMed ID: 29566269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of the Alcohol Quality of Life Scale (AQoLS): a new patient-reported outcome measure to assess health-related quality of life in alcohol use disorder.
    Luquiens A; Whalley D; Crawford SR; Laramée P; Doward L; Price M; Hawken N; Dorey J; Owens L; Llorca PM; Falissard B; Aubin HJ
    Qual Life Res; 2015 Jun; 24(6):1471-81. PubMed ID: 25407634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What Outcomes are Important for Gout Patients? In-Depth Qualitative Research into the Gout Patient Experience to Determine Optimal Endpoints for Evaluating Therapeutic Interventions.
    Tatlock S; Rüdell K; Panter C; Arbuckle R; Harrold LR; Taylor WJ; Symonds T
    Patient; 2017 Feb; 10(1):65-79. PubMed ID: 27384670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of the Systemic Lupus Erythematosus Steroid Questionnaire (SSQ): a novel patient-reported outcome tool to assess the impact of oral steroid treatment.
    Mathias SD; Berry P; De Vries J; Askanase A; Pascoe K; Colwell HH; Chang DJ
    Health Qual Life Outcomes; 2017 Feb; 15(1):43. PubMed ID: 28245854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT®) questionnaire: a new patient-reported outcome instrument for PAH.
    McCollister D; Shaffer S; Badesch DB; Filusch A; Hunsche E; Schüler R; Wiklund I; Peacock A;
    Respir Res; 2016 Jun; 17(1):72. PubMed ID: 27301413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology and Health-Related Quality of Life in Hypoparathyroidism in Norway.
    Astor MC; Løvås K; Debowska A; Eriksen EF; Evang JA; Fossum C; Fougner KJ; Holte SE; Lima K; Moe RB; Myhre AG; Kemp EH; Nedrebø BG; Svartberg J; Husebye ES
    J Clin Endocrinol Metab; 2016 Aug; 101(8):3045-53. PubMed ID: 27186861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understanding treatment burden in hemophilia: development and validation of the Hemophilia Treatment Experience Measure (Hemo-TEM).
    Brod M; Bushnell DM; Neergaard JS; Waldman LT; Busk AK
    J Patient Rep Outcomes; 2023 Feb; 7(1):17. PubMed ID: 36821002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a new patient-reported outcome measure for facial acne: the Acne Symptom and Impact Scale (ASIS).
    Alexis A; Daniels SR; Johnson N; Pompilus F; Burgess SM; Harper JC
    J Drugs Dermatol; 2014 Mar; 13(3):333-40. PubMed ID: 24595580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of the Nocturia Sleep Quality Scale: a patient-reported outcome measure of sleep impact related to nocturia.
    Romano CD; Lewis S; Barrett A; Andersson FL; Williams V; Ancoli-Israel S; Roth T
    Sleep Med; 2019 Jul; 59():101-106. PubMed ID: 31072693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Cystic Fibrosis Impact Questionnaire: qualitative development and cognitive evaluation of a new patient-reported outcome instrument to assess the life impacts of cystic fibrosis.
    McCarrier KP; Hassan M; Hodgkins P; Suthoff E; McGarry LJ; Martin ML
    J Patient Rep Outcomes; 2020 May; 4(1):36. PubMed ID: 32405878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measuring the impact of migraine for evaluating outcomes of preventive treatments for migraine headaches.
    Mannix S; Skalicky A; Buse DC; Desai P; Sapra S; Ortmeier B; Widnell K; Hareendran A
    Health Qual Life Outcomes; 2016 Oct; 14(1):143. PubMed ID: 27716228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Age- and Stage-Appropriate Patient-Reported Outcome Measure of Vision-Related Quality of Life of Children and Young People with Visual Impairment.
    Tadić V; Robertson AO; Cortina-Borja M; Rahi JS;
    Ophthalmology; 2020 Feb; 127(2):249-260. PubMed ID: 31623869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Developing item banks to measure three important domains of health-related quality of life (HRQOL) in Singapore.
    Uy EJB; Xiao LYS; Xin X; Yeo JPT; Pua YH; Lee GL; Kwan YH; Teo EPS; Vaingankar JA; Subramaniam M; Chan MF; Kumar N; Ang ALC; Bautista DC; Cheung YB; Thumboo J
    Health Qual Life Outcomes; 2020 Jan; 18(1):2. PubMed ID: 31898541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and content validity of the Lupus Foundation of America rapid evaluation of activity in lupus (LFA-REAL™): a patient-reported outcome measure for lupus disease activity.
    Askanase AD; Daly RP; Okado M; Neville K; Pong A; Hanrahan LM; Merrill JT
    Health Qual Life Outcomes; 2019 Jun; 17(1):99. PubMed ID: 31174541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Modular Health-Related Quality of Life Instrument for Electronic Assessment and Treatment Monitoring: Web-Based Development and Psychometric Validation of Core Thrive Items.
    Wicks P; McCaffrey S; Goodwin K; Black R; Hoole M; Heywood J
    J Med Internet Res; 2019 Jan; 21(1):e12075. PubMed ID: 30681962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.